ISLAND PHARMACEUTICALS LTD

Island Pharmaceuticals stock falls 5.88% on March 23, 2026, trading at AUD 0.33 with a market cap of AUD 100.7 m – see key price stats.

Island Pharmaceuticals rises 3.03% on Oct 22, 2026, amid a sharp 18.56% decline from the previous month‑end; discover why the drug‑research stock is trending.

Island Pharma’s shares drop 21% and sit below the 200‑day SMA as investors watch its viral‑therapeutics pipeline for a possible turnaround.

Island Pharmaceuticals dips 2.9% to A$0.33—below its 200‑day SMA and 52‑week low—while investors weigh the drug‑repurposing firm’s 2026 outlook.